9.87London

Tuesday, 26 November 2024

Worlds First Chikungunya Vaccine Approved by FDA

The first vaccine for chikungunya, an emerging mosquito-borne global health threat marked by fever and joint pain, has been granted accelerated approval by the US Food and Drug Administration (FDA). The vaccine, called Ixchiq, was granted fast-track and breakthrough-therapy designations in June, and the application has now received a priority…

Researchers explain how petrochemicals fuel cancer risks

A researcher with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators have penned a commentary highlighting how petrochemicals are a major contributor to cancer risks, resulting in a profoundly negative impact on overall health. Their viewpoint article in JAMA Oncology explains how the…

Impact of cancer predisposing variants on mortality examined in survivors

Childhood cancer survivors who are carriers of cancer predisposing variants have increased subsequent malignant neoplasm-related late mortality, according to a study published in the October issue of The Lancet Oncology. Cheng Chen, from the Shanghai Jiao Tong University School of Medicine, and colleagues used data from two retrospective cohort studies—St….

Novel Toothpaste May Cut Peanut Allergy Risk for Adults

ANAHEIM, California — A specially formulated toothpaste (INT301, Intrommune Therapeutics) met its safety endpoints as an oral immunotherapy to help adults with peanut allergy reduce their reaction risk, according to findings of a phase 1 study. The 48-week, randomized, double-blind, placebo-controlled trial enrolled 32 adults aged 18–55 with peanut allergy…

Experts Reveal the Secret to Being Happy and Contented

No matter what our situation is, we all dream to become happy. We dream of living a life full of positivity and vigor. We want to wake up every day with peace of mind and accomplish our tasks and goals productively. However, dealing with work stress, toxic people and environment,…

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Reviewed A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators. Jennifer Chan, MD, MPH, director of the Program in Carcinoid and Neuroendocrine…

Pharmacist reveals ingenius trick to relieve ear ache

Pharmacist reveals INGENIUS hack to relieve earache using a glass and wet tissue Doctor of Pharmacy Angela Dori stuns her 587k TikTok followers with smart hack Holding a glass against ear creates a vacuum that is said to unblock the ear canal READ MORE: What happens to your body after…

Can Some Patients With Esophageal Cancer Avoid Surgery?

MADRID — More than one third of patients with locally advanced esophageal cancer who have a complete clinical response to neoadjuvant chemoradiotherapy may be able to safely avoid major surgery, findings from the Dutch SANO-trial suggest. After 2 years, researchers found no significant differences in overall and disease-free survival between…